I did a double take at the headline. In middle-aged and older adults, obesity no longer carries the cardiovascular burden it used to, while in young adults the same extra weight is biting harder and arriving earlier than before. Same condition, opposite trajectories, split by age. My first reaction was not relief. It was suspicion, because bodies do not rewrite their own biology in a single generation. Something else changed, and I wanted to know what.

The finding comes from a large longitudinal analysis, and the shape of it is straightforward: the metabolic and cardiovascular gap between older adults with obesity and their normal-BMI peers has narrowed to the point where, on the standard panel, the two groups increasingly look alike. So the question a curious reader should ask is what “metabolically similar” even means, because there are two very different ways to close that gap. One is that the heavier body genuinely got healthier. The other is that we papered over the difference with a pharmacy.

My read is that it is mostly the pharmacy, and I do not think that is good news wearing good news’s clothes. That is an interpretation, not something the study proves, so let me show you why I land there.

Think about what typically manages a 65-year-old with obesity today. The LDL is usually held down by a statin. The blood pressure sits on an ACE inhibitor or an ARB. The fasting glucose is nudged into range by metformin, and increasingly by a GLP-1 drug that also strips off some of the weight. Every one of those numbers, the ones we read off a panel to call someone “metabolically healthy,” is a managed number. Draw the labs and they look clean. But the panel is reporting on the medication as much as on the body underneath it.

And here is the part I keep chewing on, the thing the tidy lab report hides. The visceral fat is still there. It still sits on the liver and wraps the organs, still pours free fatty acids and inflammatory signals into the bloodstream, still wears down the body’s insulin response from the inside. A statin lowers the LDL you measure; it does nothing to the fat driving the inflammation upstream. So the number on the page drifts toward the lean person’s number while the biology underneath stays exactly as loud as it ever was. We did not quiet the fire. We turned down the smoke alarm.

If that sounds like a reach, look at what happens when you take the drug scaffold away and just measure bodies honestly. A global analysis of more than 470,000 adults across 91 countries, published in JAMA, found that more than one in five people with a perfectly normal BMI are carrying abdominal obesity, a waist of at least 94 centimeters in men or 80 in women, and that hidden belly fat tracked with cardiometabolic risk. BMI, the ruler we have leaned on for a century, misses it entirely. A “normal weight” reading and a slim waist are not the same thing, and the difference is exactly the visceral fat that no lipid panel confesses to.

The whole idea of “metabolically healthy obesity” is shakier than it sounds. One analysis argued the phrase is essentially a misnomer: the components of metabolic syndrome climb with BMI in a near-straight line and keep climbing with age, so only 7.5 percent of people with a BMI over 30 have zero of those components, and under 1 percent do by a BMI of 36. “Healthy” obesity, in other words, is mostly a way station rather than a destination. And when researchers followed 381,363 people in the UK Biobank, those tagged metabolically healthy but obese still ran a 4.32-fold higher rate of diabetes, a 1.76-fold higher rate of heart failure, and a 1.18-fold higher rate of cardiovascular disease than lean, metabolically healthy people. Healthy-for-now is not the same as healthy.

I want to be honest about what this new age-split signal is. It is an observational pattern, not a randomized trial, and no one is ever going to randomize people to decades of obesity to settle it. Read flat, it says older obese bodies now post friendlier numbers. Read with the mechanism in view, it says we have gotten very good at medicating the readouts of obesity in people old enough to have accumulated a prescription list, and not good at all at preventing the disease in the young, who show up already metabolically frayed and usually without that same wall of drugs between them and the damage.

That younger half is the one that should keep us up. Obesity is arriving earlier, and in younger bodies the consequences land harder and sooner, before the statins and the GLP-1s and the years of managed numbers ever enter the picture. The convergence at the top of the age range is a monument to pharmacology. The divergence at the bottom is a warning about where this is actually headed.

So what I take from all of this is not that obesity got safe for older people. It is that a normal lab panel has quietly stopped meaning what I used to assume it meant. I do not read a clean lipid report as a clean bill of health if the waist is still there. I measure the waist, not just the scale, because that is the one number nobody is medicating into looking fine. And if it were my “perfect” labs sitting on top of visceral fat, I would treat them as the managed numbers they are and go after the fat anyway.

Sources

  1. MedPage Today – Older Folks With Obesity Now Often Metabolically Similar to Those With Normal BMI (2026)
  2. JAMA – Normal BMI With Abdominal Obesity Associated With Cardiometabolic Risks (2025)
  3. Metabolically Healthy Obesity Is a Misnomer: Components of the Metabolic Syndrome Linearly Increase With BMI as a Function of Age and Gender (2023)
  4. Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants (2021)